Publicacións en colaboración con investigadores/as de University of Giessen (1)

2001

  1. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study

    Critical Care Medicine, Vol. 29, Núm. 4, pp. 765-769